Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial

被引：0
|
作者：
Morrow, David A.
Cannon, Christopher P.
Zannad, Faiz
Cushman, William C.
Bakris, George L.
Nissen, Steven E.
Heller, Simon R.
Bergenstal, Richard M.
Perez, Alfonso T.
Fleck, Penny R.
Mehta, Cyrus R.
Kupfer, Stuart
Lam, Hung
Wilson, Craig
White, William B.
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Diabetes (Type II); Coronary heart disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17295
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Predictors of long-term cardiovascular outcomes in patients with type 2 diabetes mellitus
    Bianco, H.
    Helfenstein, T.
    Izar, M. C.
    Fonseca, H. A.
    Fischer, S. C.
    Ferreira, C. E.
    Xavier, H. T.
    Povoa, R. M.
    Fonseca, F. A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 893 - 893
  • [2] Serial high sensitivity troponin I and long-term outcomes in patients with type 2 diabetes mellitus in the EXAMINE trial
    Morrow, D. A.
    Jarolim, P.
    Cavender, M.
    Lei, L.
    Cannon, C. P.
    White, W. B.
    EUROPEAN HEART JOURNAL, 2016, 37 : 230 - 231
  • [3] Renal Outcomes Associated with Alogliptin vs. Placebo in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndrome: Results from the EXAMINE Trial
    Vaduganathan, Muthiah
    White, William B.
    Charytan, David M.
    Wilson, Craig
    Kupfer, Stuart
    Lei, Lanyu
    Liu, Yuyin
    Zannad, Faiez
    Cannon, Christopher P.
    Bakris, George L.
    DIABETES, 2016, 65 : A316 - A316
  • [4] BIOMARKERS ASSOCIATED WITH LONG TERM CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Tria Bianco, H.
    Izar, M. C.
    Helfenstein, T.
    Fonseca, H. R.
    Fischer, S. C.
    Ferreira, C. E.
    Barbosa, S. P.
    Povoa, R. M.
    Fonseca, F. A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 109 - 109
  • [5] Renal Biomarkers Predict Long-Term Adverse Events in Patients With Type 2 Diabetes Mellitus and Recent Acute Coronary Syndrome: Insights From the EXAMINE Trial
    Vaduganathan, Muthiah
    White, William B.
    Charytan, David M.
    Morrow, David A.
    Liu, Yuyin
    Wilson, Craig
    Kupfer, Stuart
    Zannad, Faiez
    Cannon, Christopher P.
    Bakris, George L.
    CIRCULATION, 2016, 134
  • [6] Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
    Joseph, Joshua J.
    Donner, Thomas W.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 107 - 116
  • [7] Long-term echocardiographic assessment in patients with type 2 diabetes mellitus treated with pioglitazone
    Schneider, RL
    Shaffer, SJ
    DIABETES, 2000, 49 : A124 - A124
  • [8] Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease
    Leiter, L. A.
    Cefalu, W. T.
    de Bruin, T. W. A.
    Xu, J.
    Parikh, S.
    Johnsson, E.
    Gause-Nilsson, I.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 766 - 774
  • [9] GlycA and Long-term Outcome in Patients with Type 2 Diabetes mellitus in Secondary cardiovascular Prevention
    Zierfuss, Bernhard
    Hoebaus, Clemens
    Herz, Carsten T.
    Pesau, Gerfried
    Mrak, Daniel
    Koppensteiner, Renate
    Schernthaner, Gerit-Holger
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 6) : 234 - 234
  • [10] Long-Term Outcomes of COVID-19 in Hospitalized Type 2 Diabetes Mellitus Patients
    Khamidullina, Zemfira
    Avzaletdinova, Diana
    Gareeva, Diana
    Morugova, Tatyana
    Lakman, Irina
    Kopp, Kristen
    Fiedler, Lukas
    Motloch, Lukas J.
    Zagidullin, Naufal
    BIOMEDICINES, 2024, 12 (02)
12345